It is now believed that the average person carries the equivalent of a spoonful of microplastics inside their body — with emerging research suggesting significant accumulation in organs such as the brain.
Yet despite growing scientific concern, microplastics remain largely ignored in conventional cancer care.
In this episode of Outsmart Cancer, Dr. Dino Prato explains how microplastics function as invisible internal contaminants that drive chronic inflammation, oxidative stress, immune suppression, and genetic instability — all of which create conditions that allow cancer to grow, spread, and resist treatment.
Dr. Prato explores how microplastics interfere with tumor-suppressive pathways such as p53 and NF-kappa B, disrupt hormonal signaling, and overload detoxification systems — weakening immune surveillance and reducing the effectiveness of chemotherapy, immunotherapy, and targeted treatments.
Because complete avoidance is impossible in a plastic-saturated world, this episode explains why reducing total toxic burden is essential for healing. Dr. Prato outlines the only clinically applied method currently available to help remove microplastics, heavy metals, and inflammatory signaling from the bloodstream, allowing immune function to recover and cancer therapies to work more effectively.
🎯 What You’ll Learn in This Episode:
📍 Envita Medical Centers – Scottsdale, AZ
🌐 Learn more: www.envita.com
📞 Speak with a care coordinator: 866-830-4576
Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.
You can read the full peer-reviewed study at:
https://www.scirp.org/journal/paperinformation?paperid=132493
